Upcoming Publication Alert: UW, UVM, UMassChen, CU Anschutz researchers in Annals of Family Medicine

 

I am pleased to inform you that researchers from the University of Washington, University of Vermont, UMass Chan Medical School, and University of Colorado—will have their original research article titled "Intervention Stage Completion and Behavioral Health Outcomes: An Integrated Behavioral Health and Primary Care Randomized Pragmatic Trial" published in the January/February 2025 issue (23.1) of Annals of Family Medicine.

Authors and Affiliations

• University of Washington, Seattle, Washington: Kari A. Stephens, PhD; Zihan Zheng, MS; Tracy Anastas, PhD; Kris (Pui Kwan) Ma, PhD; Maria G. Prado, MPH; Kwun C. G. Chan, PhD
• University of Vermont, Burlington, Vermont: Constance van Eeghen, DrPH, MHSA, MBA; Jessica Clifton, PhD; Gail Rose, PhD
• UMass Chan Medical School, Worcester, Massachusetts: Daniel Mullin, PsyD
• University of Colorado, Denver, Colorado: Rodger Kessler, PhD

Please note that this research is embargoed until 5pm EST January 27, 2025. Dr. Stephens, the corresponding author, has been cc’d on this email. Please feel free to reach out to her for further information.

Should you need manuscript proofs or permanent links to the publication, I would be happy to provide them. Additionally, we have created a plain language summary to aid in dissemination, which can also be provided upon request. 

Following the publication, we also invite you to engage with us on social media to further amplify the paper’s reach. By creating and sharing posts about the work, and tagging our X (@AnnFamMed), Facebook, Bluesky and LinkedIn  profiles, you’ll help us extend its impact. We also encourage sharing the research in online forums, communities, and platforms where it can further benefit professionals and interested parties.

 

Please let us know how we can assist you with your promotional efforts. Thank you for your support in promoting this important work!

 

Best,

Sofia

--

Sofia Darovskikh

Communications 

Annals of Family Medicine

Brown University 

315 920 0469 

Another IBH-PC Publication: Case control study of access to medications during COVID-19 and longitudinal impact on health outcomes for primary care patients managing multiple chronic conditions

 

Another IBH-PC publication: Gail L Rose, Levi N Bonnell, Lisa W Natkin, Jennifer O’Rourke-Lavoie, Constance van Eeghen, Case control study of access to medications during COVID-19 and longitudinal impact on health outcomes for primary care patients managing multiple chronic conditions, Family Practice, 2024;, cmae074, https://doi.org/10.1093/fampra/cmae074 Abstract Background During coronavirus disease 2019 (COVID-19), people managing multiple chronic conditions (MCCs) experienced barriers to obtaining needed medications. The purposes of this paper are to (i) determine risk factors for difficulty obtaining medications during COVID-19, (ii) document reasons for the difficulty, and (iii) evaluate the impact on later physical and mental health outcomes. Method In a randomized controlled trial conducted in 2016–2021, 1969 adult primary care patients were surveyed about physical and mental health both before and during COVID-19. They reported their needs for medication during COVID-19 and any difficulty obtaining them. Reasons for difficulty accessing medications were tabulated descriptively. Logistic regression identified predictors of medication access difficulty. Multivariable linear regression modeled the relationship between access to medications and health outcomes, accounting for pre-COVID health. Results  In total 13% of participants experienced difficulty accessing needed medications. Compared to the larger sample, those participants were younger, had more MCCs, and had lower income. They were more often female, unmarried, and were facing insecurities in housing, food, or finances (all P < 0.004). Younger age and the presence of socioeconomic insecurity at baseline increased the odds of later difficulty accessing medications. Barriers to access included concerns about contracting COVID-19 (52%), physician or pharmacy inaccessibility (38%), and cost (26%). Adjusting for baseline health, difficulty accessing medications was associated with poorer health at follow up (P = 0.001). Conclusion   People with socioeconomic disadvantages experienced a disproportionate impact of difficulty obtaining medications and poorer health outcomes due to COVID-19. They may be at greater risk in the event of future pandemics and other societal disruptions.   Keywords: access to medications, COVID-19, health status, mental health, multiple chronic conditions, primary health care   Issue Section: HEALTH SERVICE RESEARCH